South Tees Reachese-Prescribing Milestone in EPR Journey, with Alcidion and Better Meds
South Tees Hospitals NHS Foundation Trust has taken the next step in its modern, modular electronic patient record (EPR) programme with Alcidion, having gone live with electronic prescribing and medication administration (ePMA) system Better Meds.
The trusthas deployed Better Meds to inpatient and outpatient areas, where it is already removing paper forms and manual processes, as well as helping busy healthcare professionals to make safe prescribing decisions.
Orion Health has been awarded the Professional Record Standards Body Quality Mark for conformance with the Core Information Standard - the first supplier to achieve this watershed on the journey to interoperable shared care records.
Philips Foundation, with its mission to provide access to quality healthcare for 100 million people a year in underserved communities by 2030, together with Philips and RAD-AID International, today announced a multi-year cross-continental partnership to promote access to diagnostic ultrasound services in ten countries. 
How are trusts and health tech suppliers going to find the people they need to develop deploy and optimise critical clinical information systems in the future? Highland Marketing's advisory board invited Paul Rice from Bradford Teaching Hospitals NHS Foundation Trust to outline how he has been thinking about the challenge. 
This new technology partnership kicked off September 1, 2022, marks the first time that Siemens Healthineers is collaborating with a municipal medical service provider to implement a concept it has successfully pursued internationally with major networked healthcare providers and full-service hospitals. 
NHS Lanarkshire has launched an electronic pre-operative assessment platform to support the delivery of next generation care pathways for its patients.
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the launch of the Digital LightCyclerⓇ System, Roche's first digital polymerase chain reaction ( PCR) system. This next-generation system detects disease and is designed to accurately quantify trace amounts of specific DNA and RNA targets not typically detectable by conventional PCR methods.